Rapid Relief

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older should carefully remove the backing from the patch and apply the sticky side directly to the affected area. The patch should not be left on the skin for more than a total of 8 hours per day. Application may be repeated as necessary, but should not exceed 3 times daily. After each use, the patch must be discarded.

For children under 12 years of age, the product is not recommended, and consultation with a physician is advised. It is essential to supervise children when they are using this product to ensure safe and appropriate application.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds, cuts, damaged, or infected skin is prohibited due to the risk of exacerbating the condition. The product should not be applied to the eyes, mouth, genitals, or any mucous membranes, as this may lead to irritation or adverse reactions. Additionally, tight bandaging or the use of heating pads, including electric heating pads, is contraindicated, as this may cause excessive skin irritation or burns. Concurrent use with other topical analgesics is also not recommended, as it may increase the risk of adverse effects.

Warnings and Precautions

For external use only. This product should be utilized strictly as directed to minimize the risk of adverse effects.

In rare instances, serious burns have been reported with the use of similar products. Therefore, it is imperative to avoid tight bandaging or the application of heating pads, including electric heating pads, as these practices may lead to excessive skin irritation or burns.

Healthcare professionals should advise patients to avoid contact with the eyes and mucous membranes. The product must not be applied to wounds or damaged skin, and concurrent use with other topical analgesics is contraindicated.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, recurrence of symptoms after resolution, or any signs of skin injury, such as pain, swelling, or blistering at the application site, as these may indicate serious burns.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of worsening conditions, the presence of redness, the development of irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days, it is advised to discontinue use and consult a healthcare professional.

Additionally, patients should seek medical attention if they experience signs of skin injury, which may include pain, swelling, or blistering at the site of application. Although rare, serious burns can occur, and prompt medical evaluation is recommended in such cases.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rapid Relief (cold relief patch 5% menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this product without consulting a physician. It is essential to supervise children during the use of this product to ensure safety and proper administration.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is important to monitor renal function tests in these patients to ensure safety and efficacy. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects associated with impaired renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication.

Healthcare providers should be aware that symptoms of overdosage may vary depending on the individual and the circumstances surrounding the exposure. In cases where an overdose is suspected, it is crucial to assess the patient’s clinical status and monitor for any adverse effects.

Management of an overdose should include immediate supportive care. This may involve the following steps:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical presentation.

2. Supportive Care: Provide symptomatic treatment as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

3. Consultation: Engage with a poison control center or a medical toxicologist for guidance on specific interventions and antidotes, if applicable.

In all cases of suspected overdose, prompt medical attention is critical to mitigate potential complications and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Serious burns have been reported in rare cases associated with the use of products of this type. Instances of burns, which may be serious, can occur particularly when signs of skin injury, such as pain, swelling, or blistering, are observed at the site of application. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds, cuts, damaged, or infected skin, and to avoid contact with the eyes, mouth, genitals, or any other mucous membranes. In the event of contact with these areas, patients should be instructed to rinse thoroughly with water.

Patients should be reminded to use the product only as directed. They should be made aware that rare cases of serious burns have been reported with similar products. It is crucial to inform patients not to bandage the area tightly or use the product in conjunction with a heating pad, such as an electric heating pad, as this may lead to excessive skin irritation or burns.

Healthcare providers should emphasize the importance of avoiding the use of this product simultaneously with other topical analgesics. Patients should be advised to discontinue use and consult a doctor if their condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days or clear up and recur within a few days. Additionally, patients should be instructed to seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the application site, as serious burns, although rare, can occur.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30℃ (59-86℉) to maintain its efficacy. Additionally, the product should be kept out of reach of children to ensure safety. Proper handling and storage conditions are crucial for preserving the integrity of the product.

Additional Clinical Information

The product is administered topically, with specific guidelines for adults and children aged 12 years and older. Patients should not leave the product on the skin for more than a total of 8 hours per day and may repeat the application as necessary, but no more than three times daily.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before using the product. Additionally, it is advised that children be supervised during use to ensure safety.

Drug Information (PDF)

This file contains official product information for Rapid Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)